» Go to news main
Molly Appeal paves the way to precision cancer treatment
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
- Cracking the code on opioid‑prescribing patterns in Nova Scotia
- Dalhousie Medicine New Brunswick launches first‑of‑its‑kind medical education podcast: The Fac Dev Lounge
- Reducing brain inflammation may be the key to slowing or even reversing cognitive decline associated with aging
- Award‑winning achievement: Researcher’s work shows how Canada's new cigarette packaging will curb smoking
- Simulation‑based education: bringing theory and practice together
- Shadowing a doctor: A student’s first day of medical school leaves a lasting impact
- Dr. Noni MacDonald to be invested into Order of Nova Scotia
- Dalhousie Medicine New Brunswick celebrates first PhD graduate from Research Department